Effect of treatment with copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE) (Q72725570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Effect of treatment with copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE) (English)

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

27 August 2023

author name string

R. P. Lisak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6199466

27 August 2023

B. Zweiman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6199466

27 August 2023

N. Blanchard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6199466

27 August 2023

L. B. Rorke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6199466

27 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6199466

27 August 2023

publication date

1 December 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

number of pages

13

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0022510X83902058?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

https://api.elsevier.com/content/article/PII:0022510X83902058?httpAccept=text/plain

27 August 2023

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Journal of the Neurological Sciences

27 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

281-293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

Effect of a synthetic polypeptide (COP 1) on patients with multiple sclerosis and with acute disseminated encephalomeylitis. Preliminary report

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Clinico-pathologic correlations in experimental allergic encephalomyelitis. II. Development of an index for quantitative assay of encephalitogenic activity of antigens

27 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Experimental allergic encephalomyelitis--susceptibility and suppression

27 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin)

27 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Multiple sclerosis: trial of a synthetic polypeptide

27 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis

27 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

27 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs

27 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Altered Distribution of Lesions After Repeated Passive Transfers of Allergic Encephalomyelitis

27 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Multiple sclerosis: evidence for immunopathogenesis

27 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

In vitro and in vivo immune responses to homologous myelin basic protein in experimental allergic encephalomyelitis

27 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis

27 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Reactive and nonreactive lymphocytes in experimental allergic encephalomyelitis. I. Possible role of macrophage-lymphocyte interactions

27 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

In vitro response to basic protein in experimental allergic encephalomyelitis: Effect of pretreatment with basic protein in incomplete adjuvant

27 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis

27 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis

27 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

27 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

27 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer

27 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit

27 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis

27 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

Molecular requirements involved in suppression of eae by synthetic basic copolymers of amino acids

27 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90205-8

27 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6199466%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference